跳转至内容
Merck
CN
  • Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning.

Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning.

Science advances (2020-08-25)
Emily R Summerbell, Janna K Mouw, Joshua S K Bell, Christina M Knippler, Brian Pedro, Jamie L Arnst, Tala O Khatib, Rachel Commander, Benjamin G Barwick, Jessica Konen, Bhakti Dwivedi, Sandra Seby, Jeanne Kowalski, Paula M Vertino, Adam I Marcus
摘要

Tumor heterogeneity drives disease progression, treatment resistance, and patient relapse, yet remains largely underexplored in invasion and metastasis. Here, we investigated heterogeneity within collective cancer invasion by integrating DNA methylation and gene expression analysis in rare purified lung cancer leader and follower cells. Our results showed global DNA methylation rewiring in leader cells and revealed the filopodial motor MYO10 as a critical gene at the intersection of epigenetic heterogeneity and three-dimensional (3D) collective invasion. We further identified JAG1 signaling as a previously unknown upstream activator of MYO10 expression in leader cells. Using live-cell imaging, we found that MYO10 drives filopodial persistence necessary for micropatterning extracellular fibronectin into linear tracks at the edge of 3D collective invasion exclusively in leaders. Our data fit a model where epigenetic heterogeneity and JAG1 signaling jointly drive collective cancer invasion through MYO10 up-regulation in epigenetically permissive leader cells, which induces filopodia dynamics necessary for linearized fibronectin micropatterning.

材料
货号
品牌
产品描述

Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
抗肌动蛋白抗体 兔抗, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗微管蛋白抗体,克隆YL1/2, clone YL1/2, Chemicon®, from rat
Sigma-Aldrich
MISSION® esiRNA, targeting human MYO10